Kevin Malloy Highlights ESC 2025 Data: TACSI and TOP-CABG Trials Redefine Post-CABG Antiplatelet Therapy
Kevin Malloy, Clinical Pharmacy Specialist at Cleveland Clinic, posted on LinkedIn:
”Post-CABG: to DAPT or not to DAPT?
AHA 2021 Coronary Revascularization Guidelines:
“In selected patients undergoing CABG, DAPT (ticagrelor/clopidogrel + aspirin) for 1 yr may be reasonable to improve vein graft patency compared with aspirin alone (class 2b, LOE B-R)”
Well two hot off the press (conference) trials from ESC 2025 are reshaping our post-CABG antiplatelet strategy:
- Population: n=2,201 *ACS* post-CABG
- Intervention: ticagrelor + aspirin (12 months, open-label)
- Comparison: aspirin *mono*therapy (yes, aspirin monotherapy post-ACS)
- Outcome: *at 1 yr* (10 yr follow-up study ongoing):
– Thrombotic (MI, stroke, revasc, death): 4.8% vs. 4.6% → HR 1.06 (95% CI: 0.72–1.56)
– Major bleeding: 4.9% vs. 2.0% → HR 2.50 (95% CI: 1.52–4.11)
But what about the GRAFT?
TOP-CABG Trial
(not yet published)
- Population: CABG (ACS and SIHD) with 1+ saphenous vein graft, SVG (these guys are more prone to thrombosis)
- Intervention: De-escalated DAPT (“De-DAPT”), ticagrelor + aspirin → *3 month*→ aspirin monotherapy
- Comparison: ticagrelor + aspirin (12 months)
- Outcome:
– SVG occlusion (1 yr post-CABG, via coronary CT/A) 10.79% in De-DAPT vs 11.19% in DAPT (difference −0.31%; 95% CI: −3.13-2.52, non-inferiority margin +3.5% met ✔️)
– Bleeding (BARC ≥2): 8.3% vs. 13.2% (HR 0.62; 95% CI: 0.48 to 0.81)
Take-home pearls: Post-CABG Antiplatelet Therapy:
– Aspirin monotherapy is appropriate for most patients after CABG — especially those with SIHD or elevated bleeding risk.
– Even in ACS or SVG grafting, pumping the brakes on DAPT by 3 months is probably the right choice — extended use rarely adds benefit and increases bleeding risk.
Always individualize:
– Assess ischemic vs bleeding risk (PRECISE-DAPT score)
– Account for prior bleeding, GI risk, and consider PPI prophylaxis
– Factor in graft type, clinical context, and patient preferences.”
Stay updated with Hemostasis Today.
-
Sep 14, 2025, 11:17Isabelle Mahé on Reduced Dose Apixaban fro Cancer-Associated VTE: API-CAT Trial Results
-
Sep 13, 2025, 10:49Ranjeet Ajmani Invites You To Join The AABB-AATM Joint Webinar on Plasma Fractionation
-
Sep 13, 2025, 10:23Peter Lenting at BIC 2025: Fantastic Lecture on FVIII Mimetics
-
Sep 13, 2025, 10:20Flora Peyvandi Shares BIC 2025 Coverage of Hemostasis & Thrombosis: 10 Posts Not To Miss
-
Sep 13, 2025, 09:54Cihan Ay: ISTH 2026 In Planning!
-
Sep 14, 2025, 12:37Ivan Budnik Highlights New Framework for Thrombus Resolution Analysis in Mouse IVC Stenosis Model
-
Sep 14, 2025, 04:16F8 Gene Variants Affect Desmopressin Response in Female Hemophilia A Carriers
-
Sep 13, 2025, 10:36Drug-Induced Immune Haemolytic Anaemia: A Decade Review by Abdul Mannan
-
Sep 13, 2025, 09:44Christelle Orlando: Type II Antithrombin Deficiency Frequently Underdiagnosed Due to Assay Limitations
-
Sep 13, 2025, 07:18Eric Topol Shares a Study on The Consequences of Our Pervasive Exposure to Micro- and Nanoplastics
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 8, 2025, 02:35Reza Shojaei on the Real Worth of Hemoglobin Oxygen Carriers – HBOCs
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 14, 2025, 06:39Abdul Mannan on Factor VIII Aurora: First Natural Gain-of-Function Mutation in Haemophilia A
-
Sep 13, 2025, 13:34Brian O Mahony on 5-Year Roctavian Gene Therapy Data from BIC2025
-
Sep 13, 2025, 10:55José Antonio García Erce: Platelet Program for the Management of the Patient's Blood
-
Sep 13, 2025, 06:49Emna Gouider Belhadjali on the Role of NMOs in Advocating for Equitable Access to Diagnosis for WGBDs
-
Sep 12, 2025, 09:30Arun V J Explains How Blood Donation Rules Differ Worldwide and Why Your Donation Saves Lives Everywhere